Skip Nav Destination
Issues
1 October 2012
-
Cover Image
Cover Image
Obesity, an established risk factor for epithelial cancers, remains prevalent in the U.S. and many other countries. Calorie restriction has been shown to act as a universal inhibitor of tumorigenesis in multiple animal models of human cancer. The effect of dietary energy balance on tumor promotion was evaluated using diet-induced changes in the epidermal proliferative response in mice following TPA treatment. ICR female mice (maintained on four diets [lean, normal, overweight, obese] for 15 weeks) were treated with either acetone or TPA, twice weekly for 2 weeks. The micropictogram featured on the cover (400 × magnification) shows a representative TPA-treated, BrdU-stained (brown) skin section excised from overweight mice. Epidermal hyperplasia (skin thickness) and BrdU incorporation were significantly greater in the overweight and obese groups when compared with the lean and normal groups (P < 0.05, Mann- Whitney U test; not shown), demonstrating that dietary energy balance modulates TPA-induced epidermal hyperproliferation. These diet-induced changes were accompanied by increased levels of cell cycle proteins that favored enhanced epidermal proliferation during tumor promotion. See article by Moore et al. (beginning on page 1236) for more information. - PDF Icon PDF LinkTable of Contents
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Minireview
Perspective
Research Articles
Aberrant Methylation of RASGRF1 Is Associated with an Epigenetic Field Defect and Increased Risk of Gastric Cancer
Hiroyuki Takamaru; Eiichiro Yamamoto; Hiromu Suzuki; Masanori Nojima; Reo Maruyama; Hiro-o Yamano; Kenjiro Yoshikawa; Tomoaki Kimura; Taku Harada; Masami Ashida; Ryo Suzuki; Hiroyuki Yamamoto; Masahiro Kai; Takashi Tokino; Tamotsu Sugai; Kohzoh Imai; Minoru Toyota; Yasuhisa Shinomura
Orally Active Vitamin D for Potential Chemoprevention of Posttransplant Malignancy
Yoshitsugu Obi; Naotsugu Ichimaru; Takayuki Hamano; Kodo Tomida; Isao Matsui; Naohiko Fujii; Masayoshi Okumi; Jun-ya Kaimori; Koji Yazawa; Yukito Kokado; Yoshiharu Tsubakihara; Norio Nonomura; Hiromi Rakugi; Shiro Takahara; Yoshitaka Isaka
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.